Related Experiment Videos

PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study

A H Ragab, P Burger, S Badnitsky

Journal of Neuro-Oncology

|January 1, 1986

Abstract:

Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase II trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.

Journal of thrombosis and haemostasis : JTH·2016

Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta.

Genetics in medicine : official journal of the American College of Medical Genetics·2015

DETECTION OF LACTOBACILLI IN MONTHLY MAIL-IN STOOL SAMPLES FROM 3-18 MONTHS OLD INFANTS AT GENETIC RISK FOR TYPE 1 DIABETES.

International journal of probiotics & prebiotics·2014

Pruritic acquired nevus of Ota.

Dermatology (Basel, Switzerland)·2013

Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes.

Diabetologia·2013

Metabolic tests to determine risk for type 1 diabetes in clinical trials.

Diabetes/metabolism research and reviews·2011

See all related articles